Copertina

Association of Food Insecurity With Disease‐Related Complications and Healthcare Utilization for Patients With Sickle Cell Disease

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Sharjeel Syed, Andrew Palmer, Austin Wesevich, Kristen Wroblewski, Gabrielle Lapping‐Carr, Radhika Peddinti, Wendy S. Darlington
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Caregiver Well‐Being and Pediatric Healthcare Utilization in Youth With Sickle Cell Disease: The Role of Caregiver and Child Factors
di: Theresa L. Kapke, et al.
Pubblicazione: (2025)

Medication Utilization Among Children With Sickle Cell Disease in the United States
di: Abiodun John Ologunowa, et al.
Pubblicazione: (2025)

Pregnancy‐ and Disease‐Related Morbidity Among Medicaid Enrollees With Sickle Cell Disease
di: Mariam Kayle, et al.
Pubblicazione: (2025)

Impact of Neighborhood Disadvantage on Preventive and Acute Care Utilization in Sickle Cell Disease
di: Ashley Catanzarite, et al.
Pubblicazione: (2024)

Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition
di: Gabriela Ramirez‐Cuebas, et al.
Pubblicazione: (2025)

Sickle Cell Disease‐Related Stigma: Quantitative Assessment From India
di: Bontha V. Babu, et al.
Pubblicazione: (2025)

Sickle Cell Disease and Hemoglobin S Prevalence in Botswana
di: Setho Ruth Taboka Kgakatsi, et al.
Pubblicazione: (2025)

Highlighting Healthcare Disparities in Sickle Cell Disease Management in Resource‐Constrained Settings: A Cross‐Sectional Study in Lebanon
di: Morgan Bou Zerdan, et al.
Pubblicazione: (2025)

Unheard and Under‐Supported: Health‐Related Quality of Life in Children, Adolescents, and Young Adults With Sickle Cell Disease
di: Desiré Fantasia, et al.
Pubblicazione: (2026)

Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease
di: Akhila Vadivelan, et al.
Pubblicazione: (2025)

The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?
di: Charles T. Quinn, et al.
Pubblicazione: (2024)

Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
di: Zachary Abramson, et al.
Pubblicazione: (2025)

Statewide Academic Performance of High School Students With Sickle Cell Disease
di: Andrew M. Heitzer, et al.
Pubblicazione: (2025)

Screening and Impact of Neuropathic Pain in Young Individuals With Sickle Cell Disease
di: Amira Adly, et al.
Pubblicazione: (2024)

Relation of Adverse Childhood Experiences to Clinical and Patient‐Reported Outcomes for Adults With Sickle Cell Disease: A Registry Study
di: Marsha Treadwell, et al.
Pubblicazione: (2025)

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study
di: Suhei C. Zuleta De Bernardis, et al.
Pubblicazione: (2026)

Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease
di: Rhayane Vitória Lopes, et al.
Pubblicazione: (2025)

How We Approach Contraception for Adolescents and Young Adults With Sickle Cell Disease
di: Maayan Leroy‐Melamed, et al.
Pubblicazione: (2025)

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada
di: Hailey M. Zwicker, et al.
Pubblicazione: (2026)

HABIT Efficacy Trial Intervention Improves Elements of General and Disease‐Specific Quality of Life in Youth With Sickle Cell Disease
di: Arlene Smaldone, et al.
Pubblicazione: (2025)

Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues
di: Caroline Vinit, et al.
Pubblicazione: (2025)

Inpatient Food Insecurity and Pediatric Hematology Oncology Hospitalization Outcomes
di: Joanna M. Robles, et al.
Pubblicazione: (2026)

Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
di: Jill S. Menell, et al.
Pubblicazione: (2025)

Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease
di: Aimee K. Hildenbrand, et al.
Pubblicazione: (2026)

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype
di: Nate Goldfarb, et al.
Pubblicazione: (2025)

Optimizing Transcranial Doppler Screening for Stroke Prevention in Young African Children With Sickle Cell Disease
di: Derby Tembo, et al.
Pubblicazione: (2025)

Does Hydroxyurea Reduce Hospital Admissions in Patients With Both Sickle Cell Disease and Dengue Fever?
di: Narcisse Elenga, et al.
Pubblicazione: (2026)

Osteopathic Manipulative Treatment: A Safe and Feasible Adjunct in Sickle Cell Disease Pain Management
di: Amber Brown, et al.
Pubblicazione: (2024)

Sensitivity and Specificity of a Signaling Question for Surveillance of Cognitive Functioning in Pediatric Sickle Cell Disease
di: Steven J. Hardy, et al.
Pubblicazione: (2025)

Engaging Parents of Children With Sickle Cell Disease in Shared Decision‐Making for Hydroxyurea: The ENGAGE‐HU Study
di: Aimee K. Hildenbrand, et al.
Pubblicazione: (2025)

Prevalence and Impact of Autism Spectrum Disorder and Selected Neurodevelopmental Diagnoses in Hospitalized Youth With Sickle Cell Disease
di: Megan M. Griffith, et al.
Pubblicazione: (2025)

Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era
di: Marianne E. Yee, et al.
Pubblicazione: (2025)

Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis
di: Jeffrey G. Edwards, et al.
Pubblicazione: (2025)

Pulmonary Dysfunction Is Associated With Sleep Study Abnormalities in Children With Sickle Cell Disease: A Multicenter Study
di: Ammar Saadoon Alishlash, et al.
Pubblicazione: (2026)

User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease
di: Christina M. Abrams, et al.
Pubblicazione: (2025)

Delayed Presentation of Transfusion‐Associated Circulatory Overload Associated With Splenic Sequestration Management in Sickle Cell Disease
di: Laura S. Duarte, et al.
Pubblicazione: (2024)

Correction to “Engaging Parents of Children With Sickle Cell Disease in Shared Decision‐Making for Hydroxyurea: The ENGAGE‐HU Study”
Pubblicazione: (2026)

Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease
di: Ashwin Patel, et al.
Pubblicazione: (2025)

Major ABO Incompatibility in Non‐Myeloablative Hematopoietic Stem Cell Transplant for Sickle Cell Disease—Not an Insurmountable Obstacle
di: Kimberly Ji Eun Chung, et al.
Pubblicazione: (2025)

Hemoglobin Richmond Masquerading as Fetal Hemoglobin in a Child With Sickle Cell Disease: A Case Report and Review of the Literature
di: Jordyn Hollander, et al.
Pubblicazione: (2025)